ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

Highlights from the San Antonio Breast Cancer Symposium 2022

Автор: VJOncology

Загружено: 2022-12-12

Просмотров: 578

Описание: Virginia Kaklamani, MD, UT Southwestern Medical Center, Dallas, TX, shares her highlights from the San Antonio Breast Cancer Symposium (SABCS) 2022, including data on endocrine-sensitive tumors and ER-positive breast cancer, a HER2 session on antibody-drug conjugates (ADCs) on HER2-positive and HER2-low disease and a session on oral SERDs and AKT inhibitors in ER-positive disease. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Highlights from the San Antonio Breast Cancer Symposium 2022

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

Hot topics in breast cancer in 2023 - what is coming next?

Hot topics in breast cancer in 2023 - what is coming next?

Optimising first-line treatment in gastric cancer through precision medicine

Optimising first-line treatment in gastric cancer through precision medicine

Выпадение волос

Выпадение волос

Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs

Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs

ВЫБРОСЬ БИСОПРОЛОЛ (КОНКОР) и ИНДАПАМИД? Главная ОШИБКА при лечении давления!

ВЫБРОСЬ БИСОПРОЛОЛ (КОНКОР) и ИНДАПАМИД? Главная ОШИБКА при лечении давления!

10-year results of a Phase III trial of low-dose tamoxifen in non-invasive breast cancer

10-year results of a Phase III trial of low-dose tamoxifen in non-invasive breast cancer

What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist

What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist

Note 2. An HbA1c of 6.5% - Dr. Bernstein's Diabetes University

Note 2. An HbA1c of 6.5% - Dr. Bernstein's Diabetes University

How To Wean Yourself Off Of Afrin〚Atkins Expert Sinus Care〛

How To Wean Yourself Off Of Afrin〚Atkins Expert Sinus Care〛

11th Annual International Spinal Deformity Symposium Podium Presentation

11th Annual International Spinal Deformity Symposium Podium Presentation

The challenges of treating early-stage TNBC

The challenges of treating early-stage TNBC

Can I Hurt my Gastric Pouch?

Can I Hurt my Gastric Pouch?

Can GAE Really Stop Your Knee Pain for Good?

Can GAE Really Stop Your Knee Pain for Good?

How is AI transforming oncology care in 2026? From evidence to clinical practice

How is AI transforming oncology care in 2026? From evidence to clinical practice

Episode 5: Biochemical Recurrence in Prostate Cancer - The View on GU | with Lalani & Wallis

Episode 5: Biochemical Recurrence in Prostate Cancer - The View on GU | with Lalani & Wallis

KEYSTEP-008: pembro-based combinations for MSI-H/dMMR mCRC

KEYSTEP-008: pembro-based combinations for MSI-H/dMMR mCRC

4-year MonarchE results: increasing benefits with abemaciclib + ET for ER+/HER2- high-risk early BC

4-year MonarchE results: increasing benefits with abemaciclib + ET for ER+/HER2- high-risk early BC

МОЙТЕ ЕЁ С СОЛЬЮ — И ОРГАНИЗМ ПЕРЕСТАНЕТ БОЛЕТЬ! - НАТАЛЬЯ БЕХТЕРЕВА

МОЙТЕ ЕЁ С СОЛЬЮ — И ОРГАНИЗМ ПЕРЕСТАНЕТ БОЛЕТЬ! - НАТАЛЬЯ БЕХТЕРЕВА

Hunger is Complicated

Hunger is Complicated

Updates in biomarker-based approach in hepatobiliary & pancreatic cancers

Updates in biomarker-based approach in hepatobiliary & pancreatic cancers

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]